Literature DB >> 23515205

CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.

François-Xavier Lescure1, Antoine Moulignier, Julien Savatovsky, Corinne Amiel, Guislaine Carcelain, Jean-Michel Molina, Sébastien Gallien, Jérôme Pacanovski, Gilles Pialoux, Homa Adle-Biassette, Françoise Gray.   

Abstract

BACKGROUND: Despite its overall efficacy, combined antiretroviral therapy (cART) has failed to control human immunodeficiency virus (HIV) infection of the central nervous system (CNS). New acute and chronic neurological complications continue to be reported.
METHODS: We conducted a retrospective study of 14 HIV-infected patients with documented encephalitis, which was initially attributed to an undetermined origin. Brain magnetic resonance imaging (MRI) uniformly revealed unusual, multiple linear gadolinium-enhanced perivascular lesions.
RESULTS: All patients had manifested acute or subacute neurological symptoms; the brain MRIs indicating diffuse brain damage. The mean duration of HIV infection was approximately 10 years, and 8 patients were immunovirologically stable. Cerebrospinal fluid abnormalities with mildly elevated protein and pleocytosis with >90% lymphocytes, predominantly CD8, were found in all but 1 patient. The mean cerebral spinal fluid HIV load was 5949 copies/mL. Six patients reported a minor infection a few days prior to neurological symptoms, 2 patients presented criteria for the immune reconstitution inflammatory syndrome of the CNS, 2 were in virological escape, and 1 developed encephalitis after interruption of cART. Brain biopsies revealed inflammatory encephalitis associated with astrocytic and microglial activation as well as massive perivascular infiltration by polyclonal CD8(+) lymphocytes. All patients had been treated with glucocorticosteroids. The long-term therapeutic response varied from excellent, with no sequalae (n = 5), to moderate, with cognitive disorders (n = 4). The mean survival time was 8 years; however, 5 patients died within 13 months of initiation of treatment.
CONCLUSIONS: CD8 encephalitis in HIV-infected patients receiving cART is a clinical entity that should be added to the list of HIV complications.

Entities:  

Keywords:  CD8 lymphocytes; HIV; central nervous system; encephalitis; glucocorticosteroids

Mesh:

Substances:

Year:  2013        PMID: 23515205     DOI: 10.1093/cid/cit175

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  43 in total

Review 1.  Punctate and curvilinear gadolinium enhancing lesions in the brain: a practical approach.

Authors:  Guillaume Taieb; Alberto Duran-Peña; Nicolas Menjot de Chamfleur; Antoine Moulignier; Eric Thouvenot; Thibaut Allou; Arnaud Lacour; Khe Hoang-Xuan; Jean Pelletier; Pierre Labauge
Journal:  Neuroradiology       Date:  2015-12-23       Impact factor: 2.804

2.  Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19.

Authors:  L Chougar; B Mathon; N Weiss; V Degos; N Shor
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-18       Impact factor: 3.825

3.  CD8 T lymphocytes encephalitis mimicking brain tumor in HIV-1 infection.

Authors:  Antoine Moulignier; Julien Savatovsky; Marc Polivka; David Boutboul; Raphael Depaz; François-Xavier Lescure
Journal:  J Neurovirol       Date:  2013-11-26       Impact factor: 2.643

4.  Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.

Authors:  Michael J Peluso; Serena Spudich
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

5.  The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes.

Authors:  Mattia Trunfio; Claudia Manini; Alice Trentalange; Andrea Boghi; Sabrina Audagnotto; Daniele Imperiale; Stefano Taraglio; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  J Neurovirol       Date:  2019-06-18       Impact factor: 2.643

Review 6.  Treating HIV Infection in the Central Nervous System.

Authors:  A Calcagno; G Di Perri; S Bonora
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

7.  Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.

Authors:  Sergio M de Almeida; Michelli F Oliveira; Antoine Chaillon; Indianara Rotta; Clea E Ribeiro; Ana Paula de Pereira; Davey Smith; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2018-09-07       Impact factor: 2.643

8.  CD8 transverse myelitis in a patient with HIV-1 infection.

Authors:  Antoine Moulignier; François-Xavier Lescure; Julien Savatovsky; Pauline Campa
Journal:  BMJ Case Rep       Date:  2014-02-06

9.  Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape.

Authors:  Sérgio Monteiro de Almeida; Indianara Rotta; Ana Paula de Pereira; Bin Tang; Anya Umlauf; Cléa Elisa Lopes Ribeiro; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2020-01-30       Impact factor: 2.643

Review 10.  Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

Authors:  Neha Vartak-Sharma; Shruthi Nooka; Anuja Ghorpade
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.